These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17067667)
21. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. Patil Y; Sadhukha T; Ma L; Panyam J J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851 [TBL] [Abstract][Full Text] [Related]
22. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres. Tzafriri AR; Lerner EI; Flashner-Barak M; Hinchcliffe M; Ratner E; Parnas H Clin Cancer Res; 2005 Jan; 11(2 Pt 1):826-34. PubMed ID: 15701873 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
24. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres. Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841 [TBL] [Abstract][Full Text] [Related]
25. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma. Yuan X; Dillehay LE; Williams JR; Williams JA Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303 [TBL] [Abstract][Full Text] [Related]
26. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303 [TBL] [Abstract][Full Text] [Related]
27. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. Xie M; Zhou L; Hu T; Yao M Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398 [TBL] [Abstract][Full Text] [Related]
28. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391 [TBL] [Abstract][Full Text] [Related]
29. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Jin C; Bai L; Wu H; Tian F; Guo G Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678 [TBL] [Abstract][Full Text] [Related]
30. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro. Xie J; Tan RS; Wang CH J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769 [TBL] [Abstract][Full Text] [Related]
31. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581 [TBL] [Abstract][Full Text] [Related]
32. The development of a novel intraperitoneal tumor-seeding prophylactic. Demetrick JS; Liggins RT; Machan L; Davis NL; Burt HM; Hunter WL Am J Surg; 1997 May; 173(5):403-6. PubMed ID: 9168076 [TBL] [Abstract][Full Text] [Related]
33. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma. Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190 [TBL] [Abstract][Full Text] [Related]
34. Simulation of intratumoral release of Etanidazole: effects of the size of surgical opening. Tan WH; Lee T; Wang CH J Pharm Sci; 2003 Apr; 92(4):773-89. PubMed ID: 12661063 [TBL] [Abstract][Full Text] [Related]
35. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128 [TBL] [Abstract][Full Text] [Related]
36. Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization. Ding L; Lee T; Wang CH J Control Release; 2005 Feb; 102(2):395-413. PubMed ID: 15653160 [TBL] [Abstract][Full Text] [Related]
37. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Nsereko S; Amiji M Biomaterials; 2002 Jul; 23(13):2723-31. PubMed ID: 12059022 [TBL] [Abstract][Full Text] [Related]
38. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901 [TBL] [Abstract][Full Text] [Related]
39. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. Ho EA; Soo PL; Allen C; Piquette-Miller M J Control Release; 2007 Jan; 117(1):20-7. PubMed ID: 17113177 [TBL] [Abstract][Full Text] [Related]